Dr Seetal Dodd has an outstanding track record of research into treatment for psychiatric disorders, including involvement in numerous clinical trials and a special interest in drug safety. His experience and expertise extends through all stages of drug development, from preclinical laboratory based drug development through to investigations of established pharmacotherapies.
Dr Seetal Dodd
9 November 2021Related Posts
CREDIT Researchers feature in Magda’s Big National Health Check
Professor Pat McGorry (Orygen) and Alfred Deakin Professor Felice Jacka
Continue Reading
Current research into new treatments for bipolar depression
A team including CREDIT CRE researchers have recently published a
Continue Reading
Impact of ultra-processed foods on the brain
Listen to the fascinating conversation that Alfred Deakin Professor Felice
Continue Reading
IMPACT researchers named on Highly Cited Researchers list
Nine Deakin University academics have been named among the world’s most influential researchers in their fields following the release of the 2023 Clarivate™ Highly Cited Researchers™ list. Four of the members are researchers at IMPACT. A Highly Cited Researcher is an individual who has demonstrated significant and broad influence in their field(s) of research. Each […]
Continue Reading